Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | hydroxyprostaglandin dehydrogenase 15-(NAD) | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | steroid dehydrogenase, putative | hydroxyprostaglandin dehydrogenase 15-(NAD) | 266 aa | 216 aa | 22.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0101 | 0.1246 | 0.1246 |
Brugia malayi | Carboxylesterase family protein | 0.0101 | 0.1246 | 0.1246 |
Echinococcus multilocularis | carboxylesterase 5A | 0.06 | 1 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.0101 | 0.1246 | 0.1246 |
Loa Loa (eye worm) | carboxylesterase | 0.0101 | 0.1246 | 0.1246 |
Echinococcus granulosus | acetylcholinesterase | 0.06 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0101 | 0.1246 | 0.1246 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 0 | 0.5 |
Echinococcus granulosus | acetylcholinesterase | 0.06 | 1 | 1 |
Loa Loa (eye worm) | carboxylesterase | 0.06 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.06 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0101 | 0.1246 | 0.1246 |
Onchocerca volvulus | 0.0101 | 0.1246 | 0.5 | |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0101 | 0.1246 | 0.1246 |
Echinococcus multilocularis | acetylcholinesterase | 0.06 | 1 | 1 |
Onchocerca volvulus | 0.0101 | 0.1246 | 0.5 | |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.06 | 1 | 1 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0101 | 0.1246 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0 | 0.5 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0101 | 0.1246 | 0.5 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.06 | 1 | 1 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0101 | 0.1246 | 0.1246 |
Echinococcus granulosus | carboxylesterase 5A | 0.06 | 1 | 1 |
Echinococcus multilocularis | acetylcholinesterase | 0.06 | 1 | 1 |
Trichomonas vaginalis | spcc417.12 protein, putative | 0.0101 | 0.1246 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0 | 0.5 |
Onchocerca volvulus | 0.0101 | 0.1246 | 0.5 | |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0 | 0.5 |
Loa Loa (eye worm) | carboxylesterase | 0.0101 | 0.1246 | 0.1246 |
Onchocerca volvulus | 0.0101 | 0.1246 | 0.5 | |
Mycobacterium tuberculosis | Carboxylesterase LipT | 0.0101 | 0.1246 | 0.5 |
Brugia malayi | Carboxylesterase family protein | 0.0101 | 0.1246 | 0.1246 |
Brugia malayi | hypothetical protein | 0.0101 | 0.1246 | 0.1246 |
Loa Loa (eye worm) | hypothetical protein | 0.06 | 1 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0101 | 0.1246 | 0.1246 |
Trichomonas vaginalis | carboxylesterase domain containing protein, putative | 0.0101 | 0.1246 | 0.5 |
Brugia malayi | Carboxylesterase family protein | 0.06 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0 | 0.5 |
Brugia malayi | Carboxylesterase family protein | 0.0101 | 0.1246 | 0.1246 |
Loa Loa (eye worm) | hypothetical protein | 0.0101 | 0.1246 | 0.1246 |
Mycobacterium ulcerans | carboxylesterase, LipT | 0.0101 | 0.1246 | 0.5 |
Onchocerca volvulus | 0.0101 | 0.1246 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.8526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.